Reversal of Viral Latency and Induction of Gag-Specific T-Cell Responses in HIV-1-Infected Adults Through Cyclic Treatment Interruption of Rosuvastatin: A Proof-of-Concept Study
Journal
Journal of acquired immune deficiency syndromes (1999)
Journal Volume
86
Journal Issue
4
Pages
500-508
Date Issued
2021
Abstract
BACKGROUND: HIV-1 infection remains incurable through combination antiretroviral therapy. Previous studies have shown statins have immunomodulatory effects, and interruption of statins may cause an immune rebound. METHODS: In this proof-of-concept study,
SDGs
Publisher
NLM (Medline)
Type
journal article